Omega-3 fatty acids for autistic spectrum disorder: a systematic review.

Stephen and his team hunted for every paper that had tested fish-oil pills in kids with autism. They found only six small studies, most with no control group. The total headcount was the children across all trials.

No study showed clear gains in language, play, or social skills. Side-effect data were almost missing. The authors label the evidence “insufficient” and warn parents not to bank on omega-3.

The same “too weak to act” message pops up again in Lim et al. (2016). That paper tells clinicians not to push pet dogs for autism stress relief, mirroring Stephen’s caution on supplements.

Yu et al. (2022) looked at early antibiotics and autism risk. Once they compared siblings, the link vanished. Like Stephen, they show that flashy biological stories often crumble under tighter methods.

İnci et al. (2021) took a different metabolic angle. They screened the kids referred only for ASD and found six rare inborn errors. Their data say: check metabolism in high-risk families, but don’t generalize to every child. Stephen’s review says the same about fish oil—tested, but not proven.

Parents still ask about fish oil at every team meeting. You can now answer with a clear “show me the data” and point to this 2009 review. Save your energy for interventions with solid backing, and keep an eye on future RCTs before stocking the clinic shelf.